Aicuris’s pritelivir is forecast to be a significant advancement for immunocompromised patients with refractory HSV ...
13d
Aicuris Receives FDA Priority Review for Pritelivir NDA and Presents New Phase 3 Data at ESCMID 2026
The U.S. Food and Drug Administration has granted Priority Review for Aicuris’ New Drug Application for pritelivir, a novel helicase primase ...
Innovative Molecules' adibelivir had a favourable pharmacokinetic profile and proved safe and efficacious in Phase I clinical ...
Cold sores, also known as fever blisters, are common, contagious outbreaks caused by the herpes simplex virus type 1, with ...
Roizman reshaped the field of virology through his work on the herpes simplex virus, laying the groundwork for efforts to ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...
A drug long used to fight cancer may soon take on a very different role. Researchers at the University of Illinois Chicago ...
SHELTON, CT / ACCESS Newswire / April 21, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...
Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced multiple presentations at the 2026 American ...
You can’t get shingles in your 20s,” her mom told her. Still, Pipps went to her dad for a second opinion. “My dad took one ...
Awareness Month. The purpose is to promote knowledge about the impact of STIs, reduce stigma and promote testing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results